Viewing nowYuhan Pregabalin Controlled-Release Tablets 75 mg (Pregabalin)
Pregabalin 150mg
Tablet · Prescription medication
Yuhan Corporation

MFDS item code 202204702 · Approved 2022.12.30 · Insurance code 642106010
Treatment of peripheral neuropathic pain in adults
This medication is used to treat pain caused by peripheral neuropathy in adults.
This medicine is administered once daily after the evening meal. It should be swallowed whole and must not be split, crushed, or chewed. As this medicine is primarily excreted by the kidneys, the dose should be adjusted in patients with impaired renal function (see “2. Patients with renal impairment”). Adults: One 150 mg tablet may be administered as the starting dose. Based on the response and tolerability of each patient, the dose may be increased at weekly intervals up to a maximum of 600 mg daily. Based on current clinical experience, if treatment with this medicine is discontinued, it should be withdrawn gradually over at least 1 week. This medicine (pregabalin 75mg) should be used only as the starting dose in patients with moderate renal impairment. ≥60: Starting dose 150 mg/day, maximum dose 600 mg/day, once daily ≥30-<60: Starting dose 75 mg/day, maximum dose 300 mg/day, once daily The safety and efficacy of this medicine have not been established in patients with severe renal impairment or end-stage renal disease with an estimated glomerular filtration rate (eGFR) below 30 mL/min/1.73m2 (see “(2) Pharmacokinetic information” under “12. Information for healthcare professionals” in the precautions for use). The safety and efficacy of this medicine have not been established in patients with hepatic impairment. The safety and efficacy of this medicine have not been established in elderly patients aged 65 years and older.
Pediatric and adolescent patients under 19 years of age: The safety and efficacy of this medicine have not been established in pediatric and adolescent patients under 19 years of age.
This medication may increase the risk of suicidal thoughts or behaviors, so if you notice mood changes or unusual behaviors during treatment, you should inform your healthcare provider immediately. Do not take this medication if you are allergic to any of its components. For diabetic patients, this medication may lead to weight gain, which may require dosage adjustments of blood sugar control medications. If you experience symptoms of angioedema, such as swelling of the face, around the mouth, or neck, discontinue use immediately and consult your healthcare provider. Elderly patients may experience dizziness or drowsiness, increasing the risk of falls or injuries, so caution is advised. Transient blurred vision or changes in vision may occur during use, so notify your healthcare provider if symptoms develop. Abruptly stopping this medication may cause withdrawal symptoms such as insomnia, headache, nausea, and anxiety; therefore, it should be reduced gradually in consultation with your healthcare provider. There is a risk of drug abuse, so patients with a history of drug abuse should be closely monitored. Patients with impaired renal function may require dosage adjustments of this medication, and discontinuation may help improve renal function. Patients with severe heart disease should use this medication with caution and consult their healthcare provider as symptoms of heart failure may occur. Concurrent use with opioid analgesics may increase central nervous system depressant effects, requiring caution. Patients with weak respiratory function or the elderly may have a risk of severe respiratory depression and may require dosage adjustments. During early pregnancy, there may be a risk of fetal malformation, so women who are pregnant or planning to become pregnant should consult their healthcare provider and use effective contraception. This medication may cause dizziness and drowsiness, so caution is needed when driving or operating hazardous machinery. Rarely, life-threatening severe skin reactions may occur, so if you experience skin rashes, blisters, fever, or other symptoms, discontinue use immediately and inform your healthcare provider. Side effects such as dizziness, drowsiness, swelling, nausea, headache, and skin rash may occur; if symptoms are severe or persistent, consult your healthcare provider. Pregnant or breastfeeding women must consult their healthcare provider before taking this medication, and during breastfeeding, they should decide whether to discontinue breastfeeding or the medication. The safety and efficacy of this medication in children and adolescents under 19 years of age have not been established, so caution is required. The elderly may need dosage adjustments due to slower drug excretion from impaired renal function. In case of overdose, symptoms such as drowsiness, confusion, seizures may appear, and immediate medical treatment should be sought, and blood dialysis may be performed if necessary. This medication should be stored out of reach of children and should not be transferred to another container for safety.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to protect it from air or moisture. It is best to maintain the storage temperature between 1 and 30 degrees Celsius.
Light apricot-colored elongated film-coated controlled-release tablet
30 tablets/box [6 tablets/PTP X 5]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowPregabalin 150mg
Tablet · Prescription medication
Yuhan Corporation

Pregabalin 75mg
Hard capsule · Prescription medication
Viatris Korea Co., Ltd.

Pregabalin 150mg
Hard capsule · Prescription medication
Viatris Korea Co., Ltd.

Pregabalin 300mg
Hard capsule · Prescription medication
Viatris Korea Co., Ltd.

Pregabalin 150mg
Hard capsule · Prescription medication
Samjin Pharmaceutical Co., Ltd.

Pregabalin 75mg
Hard capsule · Prescription medication
Samjin Pharmaceutical Co., Ltd.

Pregabalin 75mg
Hard capsule · Prescription medication
Hanmi Pharm. Co., Ltd.

Pregabalin 150mg
Hard capsule · Prescription medication
Hanmi Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.